Additionally, IGF-1 was inversely associated with blood glucose levels, highlighting its role in metabolic regulation and promoting healthier body composition during weight loss efforts (6)
It provides valuable insights into how these medications interact with the body's hormonal systems, emphasizing their role beyond weight loss
formal rulemaking is still required before compounding pharmacies can act on a reclassification
These benefits make it especially beneficial for our patients who struggle with obesity coupled with chronic conditions such as type 2 diabetes, heart disease, or metabolic syndrome
PlexusDx serves all 50 states with licensed 503A compounding pharmacies, ensuring consistent quality and regulatory compliance regardless of location
In 2005, GLP-1 medications were initially developed to help people with type 2 diabetes control their blood sugar levels